Refine
Year of publication
Document Type
- Article (44)
- Preprint (4)
- Contribution to a Periodical (3)
- Book (1)
- Conference Proceeding (1)
Language
- English (48)
- German (4)
- Multiple languages (1)
Has Fulltext
- yes (53)
Is part of the Bibliography
- no (53)
Keywords
- SARS-CoV-2 (4)
- Angiogenesis (2)
- COVID-19 (2)
- COVID19-NMR (2)
- CRM (2)
- Everolimus (2)
- Kidney transplantation (2)
- Lipidomics (2)
- Mechanisms of disease (2)
- Metabolomics (2)
- Pediatric (2)
- Solution NMR spectroscopy (2)
- Wound healing (2)
- aging (2)
- portal hypertension (2)
- stroke (2)
- 5'-UTR (1)
- 5_SL4 (1)
- 5′-UTR (1)
- ACLF (1)
- ADHD (1)
- Abductor pollicis longus (1)
- Antibody-mediated rejection (1)
- Arthroplasty (1)
- Autosomal recessive cutis laxa type 1C (1)
- Biomarker Discovery Study (1)
- Biopsy (1)
- Brain tumor (1)
- COVID (1)
- Cardiac implantable electronic devices (1)
- Cardiac rehabilitation (1)
- Cardiac resynchronization therapy (1)
- Carnivores (1)
- Cirrhosis (1)
- Colorectal cancer (1)
- Consensus document (1)
- Cytokines (1)
- Diabetes (1)
- Divergence time estimate (1)
- ECM (1)
- EET (1)
- EWSR1 (1)
- Ears (1)
- Elastogenesis (1)
- Emergency room (1)
- Endothelial progenitor cells (1)
- Epithelialization (1)
- Exercise training (1)
- Extracellular matrix (1)
- FOXO3a (1)
- Fibulin-4 (1)
- Fibulin-5 (1)
- Gene fusion (1)
- Generalist (1)
- Hashimoto’s thyroiditis (1)
- Heart failure (1)
- Implantable cardioverter-defibrillator (1)
- Inflammation (1)
- Injury (1)
- Interposition (1)
- Ischemia (1)
- K3EDTA plasma sampling (1)
- LBP (1)
- LC-MS-Based Clinical Research (1)
- Latent transforming growth factor β-binding protein 4 (1)
- Liver diseases (1)
- Ltbp-4 (1)
- Ltbp-4L (1)
- Ltbp-4S (1)
- MN1 (1)
- Metalloproteases (1)
- Molecular medicine (1)
- NMR spectroscopy (1)
- Neuroepithelial (1)
- Neurooncology (1)
- Oncogenes (1)
- PARK2 (1)
- PATZ1 (1)
- PDE‐5‐inhibitor (1)
- PTDM (1)
- Pacemaker (1)
- Phylogeography (1)
- Physical activity (1)
- Platelets (1)
- Portal veins (1)
- Post-transplant (1)
- Pre-analytics (1)
- Prevention (1)
- Prostaglandin (1)
- RNA (1)
- RNA genome (1)
- RNA-binding proteins (1)
- Randomized (1)
- RegJoint™ (1)
- SL1 (1)
- SPSS (1)
- Sampling protocol (1)
- Suspension (1)
- TOR inhibitor (1)
- Thrombosis (1)
- Thromboxane (1)
- Thumb carpometacarpal joint osteoarthritis (1)
- Trauma (1)
- Vasculogenesis (1)
- Veins (1)
- Vulpes (1)
- X-ray crystallography (1)
- accessory proteins (1)
- accident (1)
- acute decompensation (1)
- acute-on-chronic liver failure (1)
- bioactivity testing (1)
- cancer (1)
- cell-free protein synthesis (1)
- chronic low back pain (1)
- cirrhosis (1)
- computed tomography (1)
- diabetes (1)
- differentiated thyroid carcinoma (1)
- diffusion model (1)
- disease modelling (1)
- easyPACId (1)
- emergency care (1)
- erectile dysfunction (1)
- exercise (1)
- glycobiology (1)
- glycoconjugate (1)
- hepatic encephalopathy (1)
- hiPSC (1)
- infectious disease (1)
- inflammation (1)
- inflammatory reaction (1)
- injury (1)
- intrinsically disordered region (1)
- liver (1)
- lockdown (1)
- lumbago (1)
- lumbalgia (1)
- mTOR inhibitor (1)
- meta-analysis (1)
- metabolic syndromes (1)
- mitochondria (1)
- molecular modeling (1)
- motor control exercise (1)
- mtDNA control region (1)
- natural products (1)
- neovascularization (1)
- neurodegeneration (1)
- neutralizing antibodies (1)
- nonspecific (1)
- nonstructural proteins (1)
- non‐selective beta‐blocker (1)
- paper-based assessment (1)
- pediatric intensive care (1)
- portosystemic shunt (1)
- processing speed (1)
- proliferation (1)
- proteobacteria (1)
- retrovirus (1)
- sensorimotor (1)
- sialic acid (1)
- simplified production (1)
- simulation (1)
- simulation training (1)
- sirtuin1 (1)
- spike protein (1)
- spontaneous portosystemic shunt (1)
- stabilization (1)
- structural proteins (1)
- thrombolysis (1)
- thrombolysis (tPA) (1)
- training (1)
- trauma (1)
- unspecific low back pain (1)
- variants of concern (1)
- vitamin D (1)
- vitamin D receptor (1)
- wound repair (1)
Institute
- Medizin (32)
- Biochemie, Chemie und Pharmazie (7)
- Biowissenschaften (7)
- Geowissenschaften (3)
- Präsidium (3)
- Senckenbergische Naturforschende Gesellschaft (2)
- Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit (ZAFES) (2)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (2)
- Biodiversität und Klima Forschungszentrum (BiK-F) (1)
- Buchmann Institut für Molekulare Lebenswissenschaften (BMLS) (1)
Background: Protective effects of vitamin D have been reported in autoimmune and malignant thyroid diseases, though little is known about the underlying mechanism. Sirtuin 1 histon deacethylase (SIRT1) links the vitamin D pathway with regulation of transcription factor FOXO3a, a key player in cell cycle regulation and apoptosis. Aim of the present study was to investigate common single nucleotide polymorphisms (SNP's) in FOXO3a gene in respect to thyroid diseases, as well as to evaluate the hypothesis of Sirtuin1-FOXO3a interaction being a mediator of anti-proliferative vitamin D effects.
Methods: The SNP's FOXO3a rs4946936/rs4945816/rs9400239 were genotyped in 257 patients with differentiated thyroid carcinoma (DTC), 139 patients with Hashimoto thyroiditis (HT) and 463 healthy controls (HC). Moreover, T-helper cells of HC and papillary thyroid cancer cell line BCPAP were incubated with 1,25(OH)2D3 and/or SIRT1 inhibitor Ex-527 in order to elucidate SIRT1- dependent vitamin D effects on cell proliferation and FOXO3a gene expression in vitro.
Results: Patients with DTC tended to carry more often allele C in FOXO3a rs4946936 in comparison to HC (pcorrected = pc = 0.08). FOXO3a rs9400239T and rs4945816C was more frequent in HT in comparison to HC (pc = 0.02 and pc = 0.01, respectively). In both DTC and HT, we could not find a correlation of FOXO3a SNP's with vitamin D status. However, on in vitro level, 1,25(OH)2D3 showed an anti-proliferative effect in both T-helper cells and BCPAP, that was blocked by SIRT1 inhibition (T-helper cells: p = 0.0059, BCPAP: p = 0.04) and accompanied by elevated FOXO3a gene expression in T-helper cells (p = 0.05).
Conclusions: FOXO3a rs9400239T and rs4945816C may constitute risk factors for HT, independent of the vitamin D status.This indicates the implication of FOXO3a in pathogenesis of autoimmune thyroid diseases. The dependency of anti-proliferative vitamin D effects on SIRT1 activity further suggests a key role of vitamin D-SIRT1-FOXO3a axis for protective vitamin D effects.
The highly infectious disease COVID-19 caused by the Betacoronavirus SARS-CoV-2 poses a severe threat to humanity and demands the redirection of scientific efforts and criteria to organized research projects. The international COVID19-NMR consortium seeks to provide such new approaches by gathering scientific expertise worldwide. In particular, making available viral proteins and RNAs will pave the way to understanding the SARS-CoV-2 molecular components in detail. The research in COVID19-NMR and the resources provided through the consortium are fully disclosed to accelerate access and exploitation. NMR investigations of the viral molecular components are designated to provide the essential basis for further work, including macromolecular interaction studies and high-throughput drug screening. Here, we present the extensive catalog of a holistic SARS-CoV-2 protein preparation approach based on the consortium’s collective efforts. We provide protocols for the large-scale production of more than 80% of all SARS-CoV-2 proteins or essential parts of them. Several of the proteins were produced in more than one laboratory, demonstrating the high interoperability between NMR groups worldwide. For the majority of proteins, we can produce isotope-labeled samples of HSQC-grade. Together with several NMR chemical shift assignments made publicly available on covid19-nmr.com, we here provide highly valuable resources for the production of SARS-CoV-2 proteins in isotope-labeled form.
Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis
(2019)
Background: Prostanoids are important regulators of platelet aggregation and thrombotic arterial diseases. Their involvement in the development of portal vein thrombosis, frequent in decompensated liver cirrhosis, is still not investigated.
Methods: Therefore, we used pro-thrombotic venous milieu generation by bare metal stent transjugular intrahepatic portosystemic shunt insertion, to study the role of prostanoids in decompensated liver cirrhosis. Here, 89 patients receiving transjugular intrahepatic portosystemic shunt insertion were included in the study, and baseline levels of thromboxane B2, prostaglandin D2 and prostaglandin E2 were measured in the portal and the hepatic vein.
Results: While the hepatic vein contained higher levels of thromboxane B2 than the portal vein, levels of prostaglandin E2 and D2 were higher in the portal vein (all P<0.0001). Baseline concentrations of thromboxane B2 in the portal vein were independently associated with an increase of portal hepatic venous pressure gradient during short term follow-up, as an indirect sign of thrombogenic potential (multivariable P = 0.004). Moreover, severity of liver disease was inversely correlated with portal as well as hepatic vein levels of prostaglandin D2 and E2 (all P<0.0001).
Conclusions: Elevated portal venous thromboxane B2 concentrations are possibly associated with the extent of thrombogenic potential in patients with decompensated liver cirrhosis.
Trial registration: ClinicalTrials.gov identifier: NCT03584204.